Immunotherapy for IgA Nephropathy (Berger's Disease)

Immunotherapy is a great achievement in regenerative medicine. It brings infinite hope for the patients with refractory diseases in conventional medicines.

Immunotherapys are non-differentiated cells with multiple-differentiation and regeneration potentials. In right condition, they can divide into new cells with the same characteristic as the original cells or differentiate into new cells or tissues with specialized function to replace the diseased ones. Immunotherapys can be abstracted from bone narrow, peripheral blood, umbilical cord blood etc. For immunological immaturity, wide sources, free of pollution, umbilical cord blood is applied in treating IgA Nephropathy in our hospital.

At present, Immunotherapy has been used to treat cancer, kidney disease and diverse refractory diseases.

How does Immunotherapy to treat IgA Nephropathy?

IgA Nephropathy is attributable to immune dysfunction. For abnormal activation of immune system, the immune system impairs the healthy renal tissues and cells.

In treating IgA Nephropathy, after the Immunotherapy are infused into the patients'body, they can differentiate into new cells to form healthy renal tissues. In this way, the kidney structure will be rebuilt. Moreover, Immunotherapy can stimulate the body to produce normal immune cells to rebuild the patients'immune system. Therefore, the patients will be able to avoid relapses of IgA Nephropathy completely.

Immunotherapy does not cause anti-rejection problem or side effects at all. Usually, it takes 6 months for the Immunotherapy to take effect in body. Since Immunotherapy is applied in treating Kidney Disease, approximately 85% of the patients have received successful treatment.


If you want to know the recovery experience of the patients in our hospital or want to know relevant information about Immunotherapy, it is free for you to consult us on line.